Vascular effects of halothane and isoflurane: cGMP dependent and independent actions
- 30 November 1994
- journal article
- Published by Elsevier in Life Sciences
- Vol. 56 (1) , 19-29
- https://doi.org/10.1016/0024-3205(94)00403-f
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effects of Halothane on EDRF/cGMP-mediated Vascular Smooth Muscle RelaxationsAnesthesiology, 1993
- Role of Guanylate Cyclase–cGMP Systems in Halothane-induced Vasodilation in Canine Cerebral ArteriesAnesthesiology, 1992
- Isoflurane Does Not Vasodilate Rat Thoracic Aortic Rings by Endothelium-derived Relaxing Factor or Other Cyclic GMP-Mediated MechanismsAnesthesiology, 1992
- Modulation of α-adrenergic-induced contractions by endothelium-derived relaxing factor in rat aortaGeneral Pharmacology: The Vascular System, 1991
- A specific inhibitor of nitric oxide formation from l‐arginine attenuates endothelium‐dependent relaxationBritish Journal of Pharmacology, 1989
- Influence of haemoglobin and erythrocytes on the effects of EDRF, a smooth muscle inhibitory factor, and nitric oxide on vascular and non‐vascular smooth muscleBritish Journal of Pharmacology, 1988
- Endothelium-derived relaxing factorBiochemical Pharmacology, 1988
- Attenuation of Endothelium-mediated Vasodilation by HalothaneAnesthesiology, 1988
- Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.Circulation Research, 1987
- Effects of Isoflurane and Halothane on Contractility and the Cyclic 3′, 5′-Adenosine Monophosphate System in the Rat AortaAnesthesiology, 1974